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Introduction: Exercise is an important countermeasure to limb muscle dysfunction in COPD. 
The two major training modalities in COPD rehabilitation, endurance training (ET) and resis-
tance training (RT), may both be efficient in improving muscle strength, exercise capacity, and 
health-related quality of life, but the effects on quadriceps muscle characteristics have not been 
thoroughly described.
Methods: Thirty COPD patients (forced expiratory volume in 1 second: 56% of predicted, 
standard deviation [SD] 14) were randomized to 8 weeks of ET or RT. Vastus lateralis muscle 
biopsies were obtained before and after the training intervention to assess muscle morphology 
and metabolic and angiogenic factors. Symptom burden, exercise capacity (6-minute walking 
and cycle ergometer tests), and vascular function were also assessed.
Results: Both training modalities improved symptom burden and exercise capacity with no 
difference between the two groups. The mean (SD) proportion of glycolytic type IIa muscle 
fibers was reduced after ET (from 48% [SD 11] to 42% [SD 10], P0.05), whereas there was 
no significant change in muscle fiber distribution with RT. There was no effect of either train-
ing modality on muscle capillarization, angiogenic factors, or vascular function. After ET the 
muscle protein content of phosphofructokinase was reduced (P0.05) and the citrate synthase 
content tended increase (P=0.08) but no change was observed after RT.
Conclusion: Although both ET and RT improve symptoms and exercise capacity, ET induces 
a more oxidative quadriceps muscle phenotype, counteracting muscle dysfunction in COPD.
Keywords: muscle fibers, phosphofructokinase-1, vasodilation, rehabilitation, randomized con-
trolled trial
Introduction
COPD is characterized by airflow limitation causing dyspnea, exercise intolerance, and 
limb muscle dysfunction.1 The beneficial effects of exercise training on disease burden, 
exercise capacity, and muscle function are well documented in patients with COPD.1–3 
Endurance training (ET) has been the cornerstone in pulmonary rehabilitation;2 yet to 
prevent muscle weakness and atrophy, resistance training (RT) is also recommended.4,5 
A meta-analysis comparing the effects of ET and RT in patients with COPD showed 
similar improvements in health-related quality of life, exercise capacity, and leg muscle 
strength.6 However, the beneficial effects of ET and RT are probably induced by dif-
ferent muscle adaptations7 and could counteract different pathological components of 
muscle dysfunction in COPD. Limb muscle dysfunction in COPD presents as muscle 
wasting, reduced strength, fiber-type shift from type I to type II, and reduced oxidative 
capacity.1 Although studies have explored the intrinsic muscular effects of both ET 
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and RT, these studies compared COPD patients with healthy 
subjects in case-control designs.4,8–11 Thus, the ET-induced 
muscular effects have not been directly compared with RT 
in a randomized controlled trial design.
The present study explored the intrinsic quadriceps 
muscle characteristics after ET compared with RT in COPD 
patients. We hypothesized that the two training modalities 
would counteract muscle dysfunction by different mecha-
nisms: 1) ET by increasing oxidative muscle fiber propor-
tion, capillarization, and oxidative capacity; and 2) RT by 
increasing muscle fiber cross-sectional area, glycolytic fiber 
proportion, and anaerobic capacity. By obtaining biopsies 
from the vastus lateralis muscle before and after 8 weeks 
of exercise training, we tested this hypothesis in 30 patients 
with moderate-to-severe COPD randomized to either ET 
or RT. Walking distance, maximal cycling endurance, and 
symptom burden were assessed to determine whether there 
were differences in training effects between groups.
Vascular function plays an important role in regulation 
of blood supply to working skeletal muscles,12 and vascular 
function may be impaired in patients with COPD,13 but 
whether exercise training alters blood flow to the working 
muscle in COPD has not been evaluated. Thus, our second-
ary aim was to evaluate the effects of training on leg muscle 
blood flow during exercise and vascular function determined 
by flow-mediated dilation (FMD).
Methods
This was a randomized controlled trial (1:1 allocation ratio) 
of ET compared with RT in patients with COPD. Eligibility 
criteria for participants were forced expiratory volume in 
1 second/forced vital capacity ratio 0.7, forced expiratory 
volume in 1 second 80% of predicted, Modified Medical 
Research Council score 2, resting arterial oxygenation 
90%, and age between 40 and 80 years. Exclusion criteria 
were claudication, severe heart failure, unstable ischemic 
heart disease, and malignant diseases. Spirometry (Model 
2120; Vitalograph Ltd., Buckingham, UK) and a general 
medical examination were performed prior to inclusion. A 
computer-generated random allocation sequence was per-
formed, and sequentially numbered opaque sealed envelopes 
were given to the participants after inclusion and baseline 
tests. The researcher who enrolled participants and analyzed 
data was blinded to the training intervention. Sample size was 
determined using 6-minute walking distance of 54 m (stan-
dard deviation [SD] of 50 m) as the true difference (power 
80%) between groups with type 1 error risk of 5%.14
The trial was approved by the Ethics Committee of 
the Copenhagen Region (H-2-2013-150), registered on 
ClinicalTrials.gov (NCT02050945), and conducted in accor-
dance with the guidelines of the Declaration of Helsinki. 
Verbal and written informed consent was obtained from all 
subjects before enrollment.
Interventions
Both groups of patients were trained for 35 minutes, 3 times 
a week for 8 weeks. The choice of the duration and frequency 
of the training sessions was based on comparable studies 
of ET versus RT in COPD.6 All training sessions were 
supervised to ensure safety, compliance, and progression of 
training intensity. Participants performed a short warm-up 
before and a cool-down after each training session.
ET was performed at moderate intensity adjusted indi-
vidually to level 14–15 on the Borg scale of perceived 
exertion. The training sessions included either cycling on 
an ergometer or walking on a treadmill. The workload 
(Watts and distance) for each session was registered, and 
participants were instructed to increase exercise intensity 
progressively.
RT was performed on machines (Technogym, Cesena, 
Italy) and consisted of 4 sets of strength exercises of major 
upper and lower body muscle groups (chest press, rowing, 
leg press, and leg extension). The load was initially set at 
30% of one repetition maximum and increased to 40% of 
one repetition maximum. Each exercise included 4 sets with 
a duration of 30 seconds that allowed for 15–20 repetitions 
to be completed. There was a 20-second break between sets 
and a 60-second break between exercises. Subjects were 
instructed to maintain muscle tension at all times during 
sets. Workload (kilograms) was registered for all sessions, 
and intensity increased accordingly. The balance between set 
duration and rest allowed for muscular fatigue to be induced 
with a moderate load. As load was adjusted regularly to keep 
sets within the targeted repletion range, the relative training 
intensity was kept uniform among subjects.
Outcomes
symptom burden, exercise capacity, and body 
composition
The symptom burden was assessed with the COPD assess-
ment test which is a patient-completed questionnaire 
validated to monitor the impact of COPD on health-related 
quality of life (ranging from 0 to 40) where higher scores 
denote more severe impact. Exercise capacity was deter-
mined by a 6-minute walking test, peak oxygen uptake 
(VO
2
peak), and maximal workload (W
max
). After verbal 
instruction, the 6-minute walking test was performed 
between 2 marked points 30 m apart. The VO
2
peak was 
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assessed (CPET System; Cosmed, Rome, Italy) during an 
incremental bicycle ergometer exercise test that included 
5 minutes of unloaded pedaling followed by incremental 
steps of 10 W per minute until exhaustion (W
max
). The 
subject’s limit of tolerance was used as the criterion for 
finishing the test. The greatest 20-second averaged VO
2
 
was taken as the VO
2
peak. Body composition was mea-
sured by whole-body dual-energy X-ray absorptiometry 
scan (Lunar Prodigy Advance; GE Healthcare, Madison, 
WI, USA).
Muscle biopsies
After local anesthesia (lidocaine 20%) of the skin and muscle 
fascia, skeletal muscle biopsies were obtained by the Bergström 
technique15 from the vastus lateralis of the nondominant leg. 
Biopsies were separated; one part for protein analysis was 
immediately frozen in liquid nitrogen, and another part for 
histology was mounted in Tissue-Tek® (Sakura Finetek USA, 
Inc., Torrance, CA, USA) and then immediately frozen in 
isopentane precooled in liquid nitrogen.
Fiber type and capillarization
Immunohistochemistry was performed using antibodies 
against myosin heavy chain (MHC) type I and type IIa, 
endothelial cells, and laminin. Muscle fibers positive for 
antibodies against both fiber types I and IIa were considered 
intermediate. Fibers of no coloration were deemed type IIx, 
and we subsequently verified this assumption with specific 
staining. The researcher who processed and analyzed the 
biopsies was blinded toward intervention and training 
status (antibodies and detailed description are given in the 
Supplementary materials).
Muscle protein content
We measured protein content of CS, eNOS, PFK, and VEGF 
by Western blotting. The housekeeping protein GAPDH was 
used as loading control (antibodies and detailed description 
are given in the Supplementary materials).
Vascular ultrasound assessments
We assessed endothelium-dependent dilation of the superfi-
cial femoral artery with FMD.16 In brief, the arterial diameter 
was assessed by ultrasound at baseline for 2 minutes followed 
by 5-minute suprasystolic cuff inflation (~220 mmHg). FMD 
was calculated as a percentage change from baseline in peak 
diameter after deflation (Supplementary materials). After the 
FMD, the participants were placed in a one-leg kicking chair. 
Leg blood flow (LBF) in the common femoral artery was 
measured using Doppler ultrasound. LBF was measured at 
rest and during 1 minute of passive leg movements followed 
by 3-minute leg kicking at 12 W.17,18
statistical methods
Effects within training groups were analyzed using a paired 
t-test, and differences between groups with Student’s t-test 
comparing the mean change from baseline, but where the 
assumption of normality was not met, we used the Wilcoxon 
and Mann–Whitney U-tests. LBF measured at different time 
points was analyzed using a two-way analysis of variance 
with repeated measures (Holm–Sidak post hoc). Data were 
analyzed using SigmaPlot (v 13; Systat Software, San Jose, 
CA, USA). Results are presented as mean values (SD) unless 
mentioned otherwise. A two-tailed P-value 0.05 was con-
sidered statistically significant.
Results
Recruitment, training, and follow-up of participants were 
performed from February 2014 to March 2015 (Figure 1). 
The baseline characteristics of the participants are shown 
in Table 1.
The mean COPD assessment test score was reduced (less 
is better) after training in both the ET group (from 13 [SD 5] 
to 11 [SD 5], P0.05) and the RT group (from 13 [SD 4] to 
10 [SD 4], P0.05), with no significant differences between 
groups (P0.05). Six-minute walking distance and workload 
at VO
2
 peak increased in both training groups, also with no 
difference between groups (P0.05) (Table 2).
Quadriceps muscle morphology and 
capillarization
A total of 18,301 muscle fibers were identified (mean of 
482 [SD 222] fibers per biopsy). Representative transverse 
sections of muscle morphology before and after the two train-
ing modalities are shown in Figure 2A and B. We found no 
significant change in mean (SD) proportion of type I fibers 
with either of the training modalities (ET: from 34% [SD 10] 
to 36% [SD 9]; RT: from 39% [SD 12] to 36% [SD 14]), 
and there were no significant differences between groups 
(Figure 2C). In contrast, the mean (SD) proportion of type 
IIa fibers decreased after ET (from 48% [SD 11] to 42% 
[SD 10], P=0.022) but did not change significantly after RT 
(from 48% [SD 14] to 56% [SD 16], P0.05) with signifi-
cant difference between groups (P=0.040) (Figure 2D). The 
mean (SD) proportion of intermediate fibers (ET: from 13% 
[SD 6] to 15% [SD 7]; RT: from 9% [SD 5] to 8% [SD 6]) 
and type IIx fibers (ET: from 5% [SD 5] to 7% [SD 9]; RT: 
from median 2% [range 0–6] to median 1% [range 0–2]) did 
not change significantly after training, with no difference 
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Muscle protein content
Representative Western blots of CS and PFK are shown in 
Figure 3. ET tended to increase the content of CS (P=0.08), 
and there was a reduction in PFK content (P=0.049). In 
the RT group, there was no change in CS or PFK content 
(P0.05). Yet, we observed no difference between groups 
in muscle content of CS or PFK after training (P0.05). We 
found no training effects or differences between the groups 
in protein content of VEGF or eNOS (P0.05).
exercise hyperemia and vascular function
There was no statistically significant difference in LBF within 
or between the two training groups (P0.05) (Figure 4A and B). 
When data from all participants were pooled, we found a higher 
LBF during 12 W of leg kicking after the exercise training 
(P=0.03) (Figure 4C). Vascular function, assessed by %FMD 
and LBF during passive movements of the lower leg, was 
similar before and after exercise training, and no differences 
between groups were found (P0.05) (Table 2).
Discussion
This randomized controlled trial of quadriceps muscle adap-
tations to ET versus RT in patients with COPD found that 
although both training modalities improved symptom burden, 
Figure 1 Study flow diagram.
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Table 1 Baseline characteristics
RT group 
(n=15)
ET group 
(n=15)
All participants 
(n=30)
age (years) 65 (7) 60 (9) 63 (8)
Male, n 6 (40%) 7 (47%) 13 (43%)
FeV1, % of predicted 57 (12) 55 (17) 56 (14)
FeV1 (l) 1.5 (0.5) 1.7 (0.7) 1.6 (0.6)
FVC (l) 2.9 (1.0) 3.5 (1.1) 3.2 (1.1)
FVC, % 81 (25) 95 (27) 88 (26)
FeV1/FVC ratio 0.56 (0.2) 0.51 (0.1) 0.54 (0.1)
2 exacerbations/year, n 1 (7%) 3 (20%) 4 (13%)
Pack-years 42 (10) 31 (16) 36 (14)
Current smoker, n 4 (27%) 3 (20%) 7 (47%)
BMI (kg/m2) 27 (4) 27 (6) 27 (5)
systolic BP (mmhg) 139 (17) 137 (27) 138 (22)
Diastolic BP (mmhg) 86 (10) 91 (19) 89 (15)
Diagnosed hypertension, n 4 (27%) 8 (53%) 12 (40%)
Ischemic heart disease, n 1 (7%) 2 (13%) 3 (10%)
Diabetes, n 1 (7%) 2 (13%) 3 (10%)
Note: Data in mean values (standard deviation) or numbers (%).
Abbreviations: BMI, body mass index; BP, blood pressure; eT, endurance 
training; FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity; 
rT, resistance training.
between groups. We found no training effects within or 
between groups on capillarization (expressed as capillary-to-
fiber ratio and capillary density) or fiber cross-sectional area 
(Table 2).
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Table 2 symptom burden, exercise capacity, body composition, vascular function, and capillarization
ET group RT group
Baseline 
(mean [SD])
After training 
(mean [SD])
Baseline 
(mean [SD])
After training 
(mean [SD])
CaT score 13 (5) 11 (5)# 13 (4) 10 (4)#
6MWD (m) 550 (80) 589 (55)# 531 (77) 555 (67)#
Maximal workload (W) 104 (31) 116 (38)# 95 (40) 104 (41)#
VO2peak (l/min) 1.6 (0.5) 1.7 (0.5) 1.6 (0.6) 1.7 (0.6)
VO2peak (ml/kg/min) 21 (7) 22 (7) 21 (6) 23 (7)
rF max (breath/min) 36 (5) 37 (7) 39 (7) 39 (8)
Tidal volume max (l) 1.6 (0.5) 1.6 (0.4) 1.5 (0.4) 1.6 (0.5)
Minute ventilation max (l/min) 57.1 (17.2) 58.1 (14.9) 57.8 (18.6) 60.0 (20.8)
Total fat mass (kg) 25.3 (9.4) 24.1 (9.4)# 26.8 (7.8) 26.3 (7.5)
Total fat-free mass (kg) 52.1 (10.3) 52.3 (10.7) 49.5 (10.6) 49.7 (11.0)
Total lean mass (kg) 49.3 (9.8) 49.5 (10.2) 46.8 (10.0) 47.1 (10.4)
lBF, rest (l/min) 0.16 (0.07) 0.17 (0.07) 0.19 (0.08) 0.16 (0.05)
lBF, 30 seconds passive (l/min) 0.26 (0.14) 0.31 (0.24) 0.35 (0.17) 0.36 (0.18)
lBF, 60 seconds passive (l/min) 0.28 (0.16) 0.35 (0.27) 0.41 (0.19) 0.41 (0.22)
FMD, % 5 (3) 5 (3) 7 (6) 6 (6)
Change in diameter (mm) 0.3 (0.2) 0.3 (0.2) 0.4 (0.3) 0.4 (0.4)
Time to peak (seconds) 127 (57) 130 (80) 169 (86) 153 (69)
Capillary-to-fiber ratio 1.529 (0.534) 1.497 (0.547) 1.488 (0.279) 1.493 (0.388)
Capillaries per square millimeter 275 (87) 250 (94) 241 (49) 254 (61)
Cross-sectional area (µm2) 5,644 (1,250) 6,355 (2,316) 6,587 (2,506) 6,295 (2,461)
Notes: #Difference within training group (paired t-test): P0.05. no differences between groups (student’s t-test of mean change from baseline).
Abbreviations: 6MWD, 6-minute walking distance; CAT, COPD assessment test; ET, endurance training; FMD, flow-mediated dilation; LBF, leg blood flow; RF, respiration 
frequency; rT, resistance training; sD, standard deviation; VO2, oxygen uptake.
Figure 2 Fiber-type change.
Notes: (A and B) representative skeletal muscle cross-sections after immunohistochemistry were performed using antibodies against myosin heavy chain (MhC) type I 
(green), MhC IIa (red) seen under a light microscope ×10 objective. White scale bars=100 µm. Muscle sections from two participants before and after (A) eT and (B) rT. (C 
and D) Mean values of fiber-type proportions (%) with error bars (SD) in the ET group and the RT group. #Significant difference within training group (paired t-test): P0.05, 
*significant difference between groups (Student’s t-test of mean change from baseline): P0.05.
Abbreviations: eT, endurance training; MhC, myosin heavy chain; rT, resistance training.
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walking distance and maximal work load equally, leg muscles 
adapted differently. The proportion of glycolytic fibers was 
reduced after ET but not after RT. Likewise, ET induced a 
change in muscle protein content towards less glycolytic 
and more oxidative metabolism which was not observed 
after RT. Combined, the results indicate that both ET and 
RT induce functional improvements whereas ET appears 
more effective in shifting the quadriceps muscle towards a 
oxidative phenotype.
symptom burden and exercise capacity
After 8 weeks of exercise training, the symptom burden was 
reduced to the same extent in both groups. Similarly, the 
effects on 6-minute walking distance and maximal cycling 
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Figure 4 Leg muscle blood flow.
Notes: Leg blood flow (L/min) during 1 minute of passive leg movements followed by 3 minutes of leg kicking (12 W) in (A) the rT group, (B) the eT group, and (C) all 
subjects before and after the training intervention. Data are presented as mean ± standard error of mean. *Different from before training: P0.05 (two-way anOVa with 
repeated measures and holm-sidak post hoc).
Abbreviations: eT, endurance training; rT, resistance training.
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Figure 3 Muscle protein content.
Notes: representative Western blots of (A) PFK, (B) Cs, and gaPDh protein content 
in skeletal muscle from six COPD participants (#1–6). samples from the same participant 
were loaded side by side before (indicated as b) and after (indicated as a) eT and rT.
Abbreviations: Cs, citrate synthase; eT, endurance training; PFK, phospho-
fructokinase; rT, resistance training.
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workload were similar in both groups. This study confirms 
that improved functional outcome after short-term exercise 
training can be achieved with both ET and RT.6,19 Although 
we did not find a statistically significant improvement of VO
2
 
peak within groups, our results (increase by ~0.1 LO
2
/min) 
were in alignment with previous studies of RT and ET in 
COPD.6 With a larger sample size, we find it likely that 
within-group changes of VO
2
peak would have reached sta-
tistical significance.
skeletal muscle plasticity in COPD
Skeletal muscle plasticity represents the ability of the muscle 
cell to alter the amount of protein and/or the type of protein 
in response to a given stimulus.20 When comparing the 
exercise-induced adaptations of muscle fiber type, we found 
a difference between the two training groups in type IIa fiber 
distribution. Thus, the type IIa fiber proportion decreased 
after ET, but in accordance with results by Lewis et al,9 we 
did not observe a change in IIa fiber proportion after RT. 
A quadriceps muscle fiber-type shift from oxidative type I 
fibers to glycolytic type II fibers is a consistent finding in 
COPD and is related to disease severity.21 Based on studies 
of the muscular adaptations to exercise in COPD compared 
to healthy age-matched subjects, it seems that RT could 
increase cross-sectional area22 and muscle mass,4 whereas 
ET appears to increase muscle oxidative capacity.10,11,23 In the 
present study, the proportion of type I fibers at baseline was 
low compared to reference values established in a healthy 
elderly population,24 and although not as low as observed 
in severe COPD,21 the results were similar to results from 
studies of milder staged COPD.25,26 Even though our results 
did not show an increase in type I fiber proportion after ET, 
there appears to be a potential for an adaptation toward a 
more oxidative muscle phenotype after aerobic training in 
COPD.3,25 In the transition from muscle fibers showing pure 
expression of MHCIIa proteins to pure type I fibers are inter-
mediate (MHCI/MHCIIa) fibers that co-express both MHC 
isoforms.20,27 We speculate that longer training adherence 
would induce a greater muscle fiber-remodeling response, 
possibly with recruitment of these fibers in transition.
In support of the alterations in MHC fiber type with train-
ing, we found that ET lowered the level of the rate-limiting 
glycolytic enzyme PFK and tended to increase muscle content 
of the mitochondrial oxidative enzyme CS. The CS content 
is thought to be more abundant in oxidative type I fibers than 
in the more glycolytic type IIa fibers and the highly glyco-
lytic type IIx fibers.28 In agreement, CS is reduced in COPD 
compared to healthy individuals.29 Moreover, studies indicate 
that COPD patients have a higher reliance on glycolytic 
metabolism during exercise and that upregulation of glyco-
lytic enzymes (including PFK) is related to overproduction 
of lactate in muscles compared to healthy individuals.30,31 
Ultimately, high muscle lactate can contribute to premature 
fatigue and exercise termination,26,31 but lactate may also 
stimulate central fatigue through afferent signaling from the 
exercising limb.32 Improving the oxidative capacity of the 
muscle in COPD patients would therefore likely improve 
exercise capacity.
Leg muscle blood flow and vascular 
function
Working skeletal muscle is highly dependent on sufficient 
blood supply to match the increased demand for oxygen.33 
Thus, impaired blood flow to muscles may aggravate muscle 
dysfunction in COPD. We found that during an acute bout 
of exercise, both training groups showed an initial raise and 
steady state in exercise hyperemia, as also observed in healthy 
individuals.34 There was an overall effect of training on exercise 
hyperemia, but the increase was not significant within each 
of the two groups separately. One explanation for the overall 
improvement in exercise hyperemia after training could be 
improved vascular function.12 Although previous evidence 
has indicated that the vascular function is impaired in COPD,35 
others have showed no difference in vascular function36 and 
even higher LBF response to exercise in COPD compared with 
healthy control subjects.36,37 Compared to previously reported 
data in healthy elderly individuals, our data support that vas-
cular function is impaired in COPD, as the FMD response 
was low.38 Low FMD indicates impaired nitric oxide (NO)-
mediated vasodilation,39 but NO is not an obligatory substance 
for exercise hyperemia. In the current study, vascular function 
was not improved by training as indicated by no change in 
either FMD or response to passive leg movement, another NO-
dependent test.18 Moreover, there was no change in quadriceps 
muscle protein content of eNOS after exercise training in either 
of the training groups. Another explanation for the increase in 
exercise hyperemia could be a reduced vasoconstriction after 
training. The ability to override sympathetic vasoconstrictor 
activity during exercise, termed functional sympatholysis, 
appears to impair leg muscle blood flow in patients with essen-
tial hypertension, while exercise training improves exercise 
hyperemia and functional sympatholysis.17,40
limitations
This study is explorative, and there are some limitations 
that should be considered. Because established thresholds of 
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minimal clinically important difference for muscle outcomes 
in COPD do not exist, our sample size calculation was not 
based on muscle outcome. We did not obtain sufficient muscle 
specimens from all subjects. Consequently, the paired num-
ber of samples from both pre- and post-training was smaller 
in the RT group than in the ET group for structural measures 
(n=6 versus n=13) and similarly for the analysis of muscle 
protein content (n=9 versus n=14). Maybe, the difference 
between the two training forms regarding effect on intrinsic 
muscle function is caused by that the quadriceps muscle was 
stimulated throughout all ET training sessions, but only dur-
ing approximately 50% of each RT training session. Because 
of the small sample size and explorative nature of this study, 
we did not adjust for possible confounding variables includ-
ing the age and the level of pulmonary function. Finally, we 
used perceived exertion to adjust the intensity of ET, but the 
actual exercise intensity may have varied between subjects 
depending on pulmonary function.
Conclusion and clinical implications
This study confirms that ET and RT improve symptoms and 
exercise capacity in patients with COPD. However, our data 
suggest that ET induces a more oxidative quadriceps muscle 
phenotype compared with RT. These results indicate that 
aerobic physical activity (eg, cycling or walking) at moderate 
intensity is the most efficient countermeasure of quadriceps 
muscle dysfunction in COPD, and we suggest that training of 
patients with COPD should include an aerobic component.
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Supplementary materials
Methods
Vascular ultrasound
We assessed endothelium-dependent dilation of the super-
ficial femoral artery with flow-mediated dilation (FMD). 
We used an ultrasound machine (Logic E9; GE Healthcare, 
Milwaukee, WI, USA) equipped with a probe operating at 
an imaging frequency of 9 MHz. Longitudinal ultrasound 
images of the artery were optimized in B-mode and saved 
in DICOM files until analysis. FMD was measured by the 
same sonographer at approximately the same time of the day 
before and after training, prior to 15–20 minutes of supine 
rest. A cuff (D. E. Hokanson Inc., Belevue, WA, USA) was 
placed ~10 cm above the knee, and all recordings of vessel 
diameter were made proximally of the cuff. The arterial 
diameter was assessed at baseline for 2 minutes followed by 
5-minute suprasystolic cuff inflation (~220 mmHg). Vessel 
diameter recordings were resumed from ~10 seconds before 
deflation and the following 5 minutes. The FMD was cal-
culated as a percent change from baseline in peak diameter 
after deflation. Analysis of the artery diameter was performed 
using validated software (Vascular Research Tool v. 6; 
Medical Imaging Applications LLC., Coralville, IA, USA) 
for automated border detection of the saved DICOM files.
Shortly after, the FMD subjects were placed in a one-
leg kicking chair. Leg blood flow in the common femoral 
artery was measured using Doppler ultrasound (frequency 
of 4.3–5.0 MHz). All recordings were obtained at the low-
est possible insonation angle and always 60°. The sample 
volume was maximized according to the width of the vessel 
and kept clear of the vessel walls. Doppler traces and B-mode 
images were recorded continuously, and Doppler traces were 
averaged over minimum eight heart cycles. Arterial diam-
eter was measured during the systole and two-thirds of the 
diameter during the diastole. Leg blood flow was measured 
at baseline and during 1 minute of passive leg movements 
followed by 3-minute active leg kicking at 12 W.
Immunohistochemistry
Directly after performing the muscle biopsy from the 
vastus lateralis muscle, the biopsies were prepared using 
Tissue-Tek® O.C.T.™ Compound (Sakura Finetek USA, Inc., 
Torrance, CA, USA). The biopsies were frozen immediately 
and kept at -80°C.
The muscle biopsies were cut into 8–10 µm-thin cross 
sections at -30°C using a cryostat (Microm HM500 M; 
Heidelberg, Germany), and the sections were then placed 
onto microscopy glass slides. The specimens were kept 
at -20°C until all the biopsies were cut and ready for 
immunohistochemistry.
The cross sections were then fixed for 2 minutes using a 
formaldehyde solution (F1635; Sigma-Aldrich Co., Sigma, 
MO, USA). Following rinsing the sections with a pH 
neutral 1% phosphate-buffered saline (PBS) solution, the 
specimens were blocked for 10 minutes using a 1% bovine 
serum albumin (A7906; Sigma-Aldrich Co.). The primary 
antibodies (myosin heavy chain [MHC] type I [M2421; 
Sigma-Aldrich Co.] and MHCIIa [SC-71; Developmental 
Studies Hybridoma Bank, Iowa, IA, USA]) were diluted in 
an antibody diluent (S0809; Dako Denmark A/S, Glostrup, 
Denmark) together with polyclonal rabbit anti-laminin 
(Z0097; Dako Denmark A/S), and the sections incubated 
for 50 minutes. Following a rinse with PBS solution, the 
cross sections were incubated with the secondary antibodies 
for 50 minutes. The incubations were performed at room 
temperature.
The capillaries were identified using Biotinylated Ulex 
Europaeus Agglutinin I (B-1065; Vector Laboratories, 
Burlingame, CA, USA), which marks endothelial cells. The 
applied secondary antibodies were the following: donkey 
anti-mouse IgG (H+L) secondary antibody, Alexa Fluor® 
555 conjugate (A31570; Thermo Fisher Scientific, Waltham, 
MA, USA) and streptavidin conjugated with fluorescein iso-
thiocyanate (F0422; Dako Denmark A/S); donkey anti-mouse 
IgG (H+L) secondary antibody, Alexa Fluor® 488 conjugate 
(A21202; Thermo Fisher Scientific); and goat anti-rabbit 
IgG (H+L) secondary antibody, Alexa Fluor® 350 conjugate 
(A21068; Thermo Fisher Scientific).
The cross sections were mounted using Prolong Gold 
Antifade Mountant (P36930; Life Technologies) and were 
stored at -20°C until pictures of the biopsies were taken by a 
high-resolution camera (CoolSNAP; Photometrics, Tucson, 
AZ, USA) through a light microscope (Axioplan 2 Imaging; 
Carl Zeiss Meditec AG, Jena, Germany). The muscle 
fibers and capillaries were counted using both computer 
programs, Microsoft PowerPoint (Microsoft Corporation, 
Redmond, WA, USA) and ImageJ 1.47 (National Institutes 
of Health, Bethesda, MD, USA).
Overlay pictures of the different immunofluorescent 
images taken were used when assessing the muscle fiber 
distribution of the biopsies, as type I fibers were recognized 
as those expressing MHCI, type IIa fibers as those express-
ing MHCIIa, and the intermediate fibers as those expressing 
both MHCI and MHCIIa.
Type IIx fibers were identified as those fibers lacking 
expression of both primary antibodies, MHCI and MHCIIa. 
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Staining the biopsies with a specific MHCIIx antibody 
(6H1; Developmental Studies Hybridoma Bank) validated 
this assumption.
Western blotting
Muscle specimens were cut at -20°C, and samples were 
homogenized and lysed. The protein content was measured 
(colorimetric assay; Bio-Rad Laboratories Inc., Hercules, 
CA, USA) to insure equal sample concentrations. Loading 
buffer (Thermo Fisher Scientific) and dithiothreitol were 
applied, and samples were boiled for 5 minutes. The lysate 
was loaded onto the gels (Criterion TGX 4%–15% gel; 
Bio-Rad Laboratories Inc.) where samples from one indi-
vidual (before and after training) were loaded side by side 
on the same gel. Gels were run at 105 V for ~60 minutes. 
Protein was then transferred onto a polyvinylidene fluoride 
membrane (Trans-Blot Turbo; Bio-Rad Laboratories Inc.). 
Membranes were blocked and incubated with primary 
antibodies overnight. Membranes were washed and incubated 
with secondary horseradish peroxidase-conjugated IgG anti-
body (Dako Denmark A/S). Signal was detected (Supersignal 
West Femto Luminal/Enhancer Solution; Thermo Fisher 
Scientific) and exposed (charge couple camera; Bio-Rad 
Laboratories Inc.). Blots were analyzed and quantified using 
Image Lab software (Bio-Rad Laboratories Inc.).
Primary antibodies used were the following:
1. CS (rabbit polyclonal antibody), Abcam (Cambridge, 
UK; cat# 96600)
2. eNOS (rabbit monoclonal antibody), Cell Signaling 
Technology (Danvers, MA, USA; cat# 9586)
3. GAPDH (rabbit monoclonal antibody), Cell Signaling 
Technology (cat# 2118)
4. PFK (mouse monoclonal antibody), R&D Systems, Inc. 
(Minneapolis, MN, USA; cat# MAB7687)
5. VEGF (rabbit monoclonal antibody A-20), Santa Cruz 
Biotechnology Inc. (Dallas, TX, USA; cat# SC152).
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